NDC Compounded Drug 26436-5555-1 Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate
Injection Intracavernous

Compounded Drug Product Information

NDC Product Code 26436-5555
NDC Package Code 26436-5555-1
11-Digit NDC Billing Format NDC Format for Billing
For insurance billing purposes the Centers for Medicare & Medicaid Services (CMS) created an 11 digit NDC derivative identifier. If the NDC Package code is less than 11 digits the code must be padded with leading zeros. The leading zeros must be added to the appropriate segment to create a 5-4-2 configuration.
26436555501
Package Description 5 mL in 1 SYRINGE, PLASTIC
Product Type What kind of product is this?
Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
Human Compounded Drug
Proprietary Name What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Trimix 10/7.5/0.2
Non-Proprietary Name What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Trimix 10/7.5/0.2
Substance Name What is the Substance Name?
An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate
Dosage Form Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Route Name Intracavernous - Administration within a pathologic cavity, such as occurs in the lung in tuberculosis.
Marketing Category OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Code 26436
Labeler Name What is the Labeler Name?
Name of Company corresponding to the labeler code segment of the Product NDC.
Hybrid Pharma
Substance Name Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate
Active Ingredients Information 10 ug/1 mL; 7.5 mg/1 mL; .2 mg/1 mL
Reporting Period 2021-2

NDC Crossover Products Matching Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate

NDC crossover of Trimix 10/7.5/0.2 with NDC 26436-5555 a human compounded drug with other similar products matching the same substance name (Alprostadil; Papaverine Hydrobromide; Phentolamine Mesylate) and the same administration route (intracavernous) or dosage form (injection).

Frequently Asked Questions

What is the NDC number assigned to Trimix 10/30/2?

Trimix 10/30/2 was assigned by its manufacturer with NDC product code 26436-5555. This product is a drug classified as a human compounded drug. Compounded drugs are medications created by combining or altering existing drugs to meet the specific needs of certain patients. The NDC directory only includes information about compounded drugs from facilities that choose to assign NDC numbers to their products.

Which are the NDC package codes for Trimix 10/30/2?

The NDC package code 26436-5555-1 was assigned to a 5 mL in 1 SYRINGE, PLASTIC of alprostadil; papaverine hydrobromide; phentolamine mesylate administered intracavernous via injection.

Who manufactures this product?

Trimix 10/30/2 is manufactured by an outsourced facility and labeled by Hybrid Pharma. All compounded drugs included in the NDC directory are classified as "Outsourcing Facility Compounded Human Drug Product (Exempt from Approval Requirements)". Outsourcing facilities are a type of drug compounding facility regulated under Section 503B of the FD&C Act could be eligible for exemptions from drug registration if they meet all the conditions specified under Section 503B.

Which are the NDC crossover matchings for this product?

We found 3 matching products that have the same substance, dosage form and administration route. The matching products are manufactured by Hybrid Pharma with NDC product codes 26436-5037-5, 26436-5282-1 and 26436-5352-5.